ANDAOTICSUSPENSION/DROPS
Approved
Jun 2023
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CIPROFLOXACIN AND DEXAMETHASONE (ciprofloxacin and dexamethasone) by Sentiss is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 2023.
Drug data last refreshed 18h ago
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Sentiss
India - Gurugram
Worked on CIPROFLOXACIN AND DEXAMETHASONE at Sentiss? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.